The Role of Cancer Stem Cell Markers in Ovarian Cancer
Cancers · 20.12.2023 · 16 (1) · 40
DOI: 10.3390/cancers16010040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.12.2023. Verfasst von Karolina Frąszczak und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1st Chair and Department of Oncological Gynaecology and Gynaecology, Medical University in Lublin, 20-081 Lublin, Poland. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ovarian cancer is the most lethal gynaecological cancer and the eighth most common female cancer. The early diagnosis of ovarian cancer remains a clinical problem despite the significant development of technology. Nearly 70% of patients with ovarian cancer are diagnosed with stages III–IV metastatic disease. Reliable diagnostic and prognostic biomarkers are currently lacking. Ovarian cancer recurrence and resistance to chemotherapy pose vital problems and translate into poor outcomes. Cancer stem cells appear to be responsible for tumour recurrence resulting from chemotherapeutic resistance. These cells are also crucial for tumour initiation due to the ability to self-renew, differentiate, avoid immune destruction, and promote inflammation and angiogenesis. Studies have confirmed an association between CSC occurrence and resistance to chemotherapy, subsequent metastases, and cancer relapses. Therefore, the elimination of CSCs appears important for overcoming drug resistance and improving prognoses. This review focuses on the expression of selected ovarian CSC markers, including CD133, CD44, CD24, CD117, and aldehyde dehydrogenase 1, which show potential prognostic significance. Some markers expressed on the surface of CSCs correlate with clinical features and can be used for the diagnosis and prognosis of ovarian cancer. However, due to the heterogeneity and plasticity of CSCs, the determination of specific CSC phenotypes is difficult.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Chair and Department of Oncological Gynaecology and Gynaecology, Medical University in Lublin, 20-081 Lublin, Poland.
Zitieren
APA
Frąszczak, K., & Barczyński, B. (2023). The Role of Cancer Stem Cell Markers in Ovarian Cancer. Cancers, 16(1), 40. https://doi.org/10.3390/cancers16010040
Vancouver
Frąszczak K, Barczyński B. The Role of Cancer Stem Cell Markers in Ovarian Cancer. Cancers. 2023;16(1):40. doi:10.3390/cancers16010040
BibTeX
@article{Frszczak2023,
author = {Frąszczak, Karolina and Barczyński, Bartłomiej},
title = {The Role of Cancer Stem Cell Markers in Ovarian Cancer},
journal = {Cancers},
year = {2023},
volume = {16},
number = {1},
pages = {40},
doi = {10.3390/cancers16010040}
}
EUVIMED